Investigating the complementary value of OCT to MRI in cognitive impairment in relapsing-remitting multiple sclerosis
Multiple Sclerosis Journal · 2025
DOI: 10.1177/13524585241304356 ↗Kurz gefasst
Fachartikel in der Zeitschrift Multiple Sclerosis Journal, 2025. Verfasst von Ronja Christensen und 11 weiteren Autor:innen. Beteiligte Einrichtung: Queen Square MS Centre, Department of Neuroinflammation, UCL Queen Square Institute of Neurology, Faculty of Brain Sciences, University College Londo…. Hauptthemen laut MEDLINE: Multiple Sclerosis, Relapsing-Remitting, Tomography, Optical Coherence, Cognitive Dysfunction, Magnetic Resonance Imaging. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: UCLH Biomedical Research Centre.
Abstract (Originalsprache)
Background
Cognitive decline in multiple sclerosis (MS) is associated with neuro-axonal loss, quantifiable by optical coherence tomography (OCT). Associations between OCT measures and cognition in relapsing-remitting MS (RRMS) remain incompletely investigated, particularly the added value of OCT when combined with magnetic resonance imaging (MRI). We investigated the contributions of OCT and MRI while applying stringent criteria to control for subclinical optic neuropathy.
Methods
In this cross-sectional study, 137 RRMS patients underwent OCT, Brief International Cognitive Assessment for MS (BICAMS), Expanded Disability Status Scale (EDSS) and brain MRI (lesion load, grey and white matter volume); associations were explored using linear regression models.
Results
RRMS patients (aged 40.88 ± 10.6 years; disease duration 7.95 ± 7.39 years; EDSS 2; 0–6.5) were studied. Of BICAMS, 50.36% showed impaired Symbol Digit Modalities Test (SDMT), 37.23% impaired Brief Visuospatial Memory Test and 5.11% impaired California Verbal Learning and Memory Test; better SDMT performance was associated with thicker ganglion cell-inner plexiform (GCIPL) layers for eyes unaffected by optic neuritis ( B = 0.23, 95% CI = (0.01–0.44), p = 0.03), but not when MRI measures were included ( B = 0.18, CI = (−0.03 to 0.38), p = 0.09).
Conclusion
GCIPL thinning correlates with SDMT, supporting OCT as a biomarker of cognitive dysfunction. However, GCIPL did not uniquely predict SDMT performance when including MRI measures, suggesting limited utility of OCT in predicting cognitive performance over MRI in RRMS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Queen Square MS Centre, Department of Neuroinflammation, UCL Queen Square Institute of Neurology, Faculty of Brain Sciences, University College London, London, UK.
- Neurosciences Institute, Cleveland Clinic London, London, UK.
- National Institute for Health and Care Research, University College London Hospitals Biomedical Research Centre, London, UK.
- Department of Neuropsychology, National Hospital for Neurology and Neurosurgery, London, UK.
- Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden.
ORCID-Profile: Ronja Christensen, Ahmed T Toosy, Anna He, Alan J Thompson
Förderung
- UCLH Biomedical Research Centre
Zitieren
APA
Christensen, R., Jolly, A., Yam, C., Yiannakas, M. C., Toosy, A. T., Pitteri, M., He, A., Nistri, R., Mohamud, S., Samdanidou, E., Thompson, A. J., & Ciccarelli, O. (2025). Investigating the complementary value of OCT to MRI in cognitive impairment in relapsing-remitting multiple sclerosis. Multiple Sclerosis Journal. https://doi.org/10.1177/13524585241304356
Vancouver
Christensen R, Jolly A, Yam C, Yiannakas MC, Toosy AT, Pitteri M, et al. Investigating the complementary value of OCT to MRI in cognitive impairment in relapsing-remitting multiple sclerosis. Multiple Sclerosis Journal. 2025. doi:10.1177/13524585241304356
BibTeX
@article{Christensen2025,
author = {Christensen, Ronja and Jolly, Amy and Yam, Charmaine and Yiannakas, Marios C and Toosy, Ahmed T and Pitteri, Marco and He, Anna and Nistri, Riccardo and Mohamud, Suraya and Samdanidou, Eirini and Thompson, Alan J and Ciccarelli, Olga},
title = {Investigating the complementary value of OCT to MRI in cognitive impairment in relapsing-remitting multiple sclerosis},
journal = {Multiple Sclerosis Journal},
year = {2025},
doi = {10.1177/13524585241304356}
}
EUVIMED